{
  "Variants Include": [
    {
      "Gene": "PINK1",
      "variants": [
        {
          "HGVS": "NM_004931.5:c.1220G>A",
          "cDNA Change": {
            "transcript": "NM_004931.5",
            "ref": "G",
            "alt": "A",
            "position": "1220"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "A",
            "position": "407"
          },
          "Description in input context": "This variant causes a missense change and destabilizes the PINK1 protein."
        },
        {
          "HGVS": "NM_004931.5:c.1617A>T",
          "cDNA Change": {
            "transcript": "NM_004931.5",
            "ref": "A",
            "alt": "T",
            "position": "1617"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "T",
            "position": "539"
          },
          "Description in input context": "This variant leads to premature stop codon."
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Hereditary Myopathy",
    "MONDO": "MONDO:0012345"
  },
  "Experiment Method": [
    {
      "Assay Method": "Western Blot",
      "Material used": {
        "Material Source": "Patient-derived fibroblasts",
        "Material Name": "Fibroblasts from patients with Hereditary Myopathy",
        "Description": "Fibroblasts were cultured and treated as described previously (Smith et al., 1998)."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_004931.5:c.1220G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "complete loss-of-function",
          "Result Description": "The levels of PINK1 protein were significantly reduced in patient-derived fibroblasts carrying NM_004931.5:c.1220G>A. Western blot analysis revealed a reduction of 75% compared to controls."
        },
        {
          "Variant": "NM_004931.5:c.1617A>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "complete loss-of-function",
          "Result Description": "The levels of PINK1 protein were completely absent in patient-derived fibroblasts carrying NM_004931.5:c.1617A>T. Western blot analysis revealed no detectable protein signal compared to controls."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Each experiment was performed with fibroblasts from three separate patients."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was run in triplicate on a single blot."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Fibroblasts from healthy donors were used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Fibroblasts treated with a proteasome inhibitor (MG132) were used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "No",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Student's t-test was used to compare protein levels between patient-derived fibroblasts and controls."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Protein expression between 80% and 120% of the mean for healthy donor fibroblasts.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Protein expression below 80% or above 120% of the mean for healthy donor fibroblasts.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}